Omdia expects revenue for ultrasound systems to contract by 8.4% in 2020, but to pick up again in 2021.
COVID-19 has had an unimaginable impact on the world and has altered virtually every sector of the medtech industry. The pandemic has had a complex and unprecedented effect on the ultrasound market.
Health care providers are using ultrasound systems, primarily designed for point-of-care (POC) applications, for the triage, monitoring, and diagnosis of COVID-19 patients
Global investment in consumer healthtech increased by 9% year-over-year in 2024, totaling $4.5bn, with significant interest in mental health solutions, according to Galen Growth. While the first quarter of 2025 saw raised confidence and investments, the Trump administration’s new tariffs and sweeping changes to healthcare have introduced new uncertainties.
Back-to-back meetings at LSX? No time to attend the innovator showcase? Here is what you might have missed from medtech innovators at the LSX World Congress Europe on 29 April.
While Roche continues to view China as a strategic growth market, a sharp 23% decline in Chinese diagnostics sales offset gains in other regions and segments. Despite near-term headwinds, Roche is betting on strong instrument placement growth across its Core Lab, Molecular, and Near Patient Care segments to fuel future demand for consumables and services–key components of its long-term medtech strategy.
